Global Non-opioid Pain Patches Market Growth 2025-2031
The global Non-opioid Pain Patches market size is predicted to grow from US$ 685 million in 2025 to US$ 803 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Non-opioid Pain Patches is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Non-opioid Pain Patches is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Non-opioid Pain Patches is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Non-opioid Pain Patches players cover Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Pain Patches Industry Forecast” looks at past sales and reviews total world Non-opioid Pain Patches sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patches sales for 2025 through 2031. With Non-opioid Pain Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patches industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Pain Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patches and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patches.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Non-opioid Pain Patches market?
What factors are driving Non-opioid Pain Patches market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patches market opportunities vary by end market size?
How does Non-opioid Pain Patches break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Non-opioid Pain Patches is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Non-opioid Pain Patches is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Non-opioid Pain Patches is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Non-opioid Pain Patches players cover Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Pain Patches Industry Forecast” looks at past sales and reviews total world Non-opioid Pain Patches sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patches sales for 2025 through 2031. With Non-opioid Pain Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patches industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Pain Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patches and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patches.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lidocaine Patch
- Diclofenac Patch
- Methyl Salicylate Patch
- Capsaicin Patch
- Ketoprofen Patch
- Others
- Hospital Pharmacies
- Independent Pharmacies & Drug Stores
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GlaxoSmithKline
- Johnson & Johnson
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries
- Hisamitsu Pharmaceutical
- TEH SENG Pharmaceutical
- Teikoku Seiyaku
- IBSA Institut Biochimque SA
- Acorda Therapeutics
- Allergan PLC
- Endo International
What is the 10-year outlook for the global Non-opioid Pain Patches market?
What factors are driving Non-opioid Pain Patches market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patches market opportunities vary by end market size?
How does Non-opioid Pain Patches break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bath and Shower Products Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bath and Shower Products by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bath and Shower Products by Country/Region, 2020, 2024 & 2031
2.2 Bath and Shower Products Segment by Type
2.2.1 Shower Products
2.2.2 Liquid Bath Products
2.2.3 Bath Additives
2.2.4 Bar Soaps
2.3 Bath and Shower Products Sales by Type
2.3.1 Global Bath and Shower Products Sales Market Share by Type (2020-2025)
2.3.2 Global Bath and Shower Products Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bath and Shower Products Sale Price by Type (2020-2025)
2.4 Bath and Shower Products Segment by Application
2.4.1 Supermarkets and Hypermarkets
2.4.2 Specialist Stores
2.4.3 Drugstores
2.4.4 Others
2.5 Bath and Shower Products Sales by Application
2.5.1 Global Bath and Shower Products Sale Market Share by Application (2020-2025)
2.5.2 Global Bath and Shower Products Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bath and Shower Products Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Bath and Shower Products Breakdown Data by Company
3.1.1 Global Bath and Shower Products Annual Sales by Company (2020-2025)
3.1.2 Global Bath and Shower Products Sales Market Share by Company (2020-2025)
3.2 Global Bath and Shower Products Annual Revenue by Company (2020-2025)
3.2.1 Global Bath and Shower Products Revenue by Company (2020-2025)
3.2.2 Global Bath and Shower Products Revenue Market Share by Company (2020-2025)
3.3 Global Bath and Shower Products Sale Price by Company
3.4 Key Manufacturers Bath and Shower Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bath and Shower Products Product Location Distribution
3.4.2 Players Bath and Shower Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BATH AND SHOWER PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Bath and Shower Products Market Size by Geographic Region (2020-2025)
4.1.1 Global Bath and Shower Products Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bath and Shower Products Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bath and Shower Products Market Size by Country/Region (2020-2025)
4.2.1 Global Bath and Shower Products Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bath and Shower Products Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bath and Shower Products Sales Growth
4.4 APAC Bath and Shower Products Sales Growth
4.5 Europe Bath and Shower Products Sales Growth
4.6 Middle East & Africa Bath and Shower Products Sales Growth
5 AMERICAS
5.1 Americas Bath and Shower Products Sales by Country
5.1.1 Americas Bath and Shower Products Sales by Country (2020-2025)
5.1.2 Americas Bath and Shower Products Revenue by Country (2020-2025)
5.2 Americas Bath and Shower Products Sales by Type (2020-2025)
5.3 Americas Bath and Shower Products Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bath and Shower Products Sales by Region
6.1.1 APAC Bath and Shower Products Sales by Region (2020-2025)
6.1.2 APAC Bath and Shower Products Revenue by Region (2020-2025)
6.2 APAC Bath and Shower Products Sales by Type (2020-2025)
6.3 APAC Bath and Shower Products Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bath and Shower Products by Country
7.1.1 Europe Bath and Shower Products Sales by Country (2020-2025)
7.1.2 Europe Bath and Shower Products Revenue by Country (2020-2025)
7.2 Europe Bath and Shower Products Sales by Type (2020-2025)
7.3 Europe Bath and Shower Products Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bath and Shower Products by Country
8.1.1 Middle East & Africa Bath and Shower Products Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bath and Shower Products Revenue by Country (2020-2025)
8.2 Middle East & Africa Bath and Shower Products Sales by Type (2020-2025)
8.3 Middle East & Africa Bath and Shower Products Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bath and Shower Products
10.3 Manufacturing Process Analysis of Bath and Shower Products
10.4 Industry Chain Structure of Bath and Shower Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bath and Shower Products Distributors
11.3 Bath and Shower Products Customer
12 WORLD FORECAST REVIEW FOR BATH AND SHOWER PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Bath and Shower Products Market Size Forecast by Region
12.1.1 Global Bath and Shower Products Forecast by Region (2026-2031)
12.1.2 Global Bath and Shower Products Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bath and Shower Products Forecast by Type (2026-2031)
12.7 Global Bath and Shower Products Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Bath and Shower Products Product Portfolios and Specifications
13.1.3 Johnson & Johnson Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 L'Oreal
13.2.1 L'Oreal Company Information
13.2.2 L'Oreal Bath and Shower Products Product Portfolios and Specifications
13.2.3 L'Oreal Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 L'Oreal Main Business Overview
13.2.5 L'Oreal Latest Developments
13.3 P&G
13.3.1 P&G Company Information
13.3.2 P&G Bath and Shower Products Product Portfolios and Specifications
13.3.3 P&G Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 P&G Main Business Overview
13.3.5 P&G Latest Developments
13.4 Unilever
13.4.1 Unilever Company Information
13.4.2 Unilever Bath and Shower Products Product Portfolios and Specifications
13.4.3 Unilever Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Unilever Main Business Overview
13.4.5 Unilever Latest Developments
13.5 Colgate-Palmolive
13.5.1 Colgate-Palmolive Company Information
13.5.2 Colgate-Palmolive Bath and Shower Products Product Portfolios and Specifications
13.5.3 Colgate-Palmolive Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Colgate-Palmolive Main Business Overview
13.5.5 Colgate-Palmolive Latest Developments
13.6 Avon
13.6.1 Avon Company Information
13.6.2 Avon Bath and Shower Products Product Portfolios and Specifications
13.6.3 Avon Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Avon Main Business Overview
13.6.5 Avon Latest Developments
13.7 Bath and Body Works
13.7.1 Bath and Body Works Company Information
13.7.2 Bath and Body Works Bath and Shower Products Product Portfolios and Specifications
13.7.3 Bath and Body Works Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bath and Body Works Main Business Overview
13.7.5 Bath and Body Works Latest Developments
13.8 Coty
13.8.1 Coty Company Information
13.8.2 Coty Bath and Shower Products Product Portfolios and Specifications
13.8.3 Coty Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Coty Main Business Overview
13.8.5 Coty Latest Developments
13.9 Estee Lauder
13.9.1 Estee Lauder Company Information
13.9.2 Estee Lauder Bath and Shower Products Product Portfolios and Specifications
13.9.3 Estee Lauder Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Estee Lauder Main Business Overview
13.9.5 Estee Lauder Latest Developments
13.10 Kao
13.10.1 Kao Company Information
13.10.2 Kao Bath and Shower Products Product Portfolios and Specifications
13.10.3 Kao Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kao Main Business Overview
13.10.5 Kao Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bath and Shower Products Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bath and Shower Products by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bath and Shower Products by Country/Region, 2020, 2024 & 2031
2.2 Bath and Shower Products Segment by Type
2.2.1 Shower Products
2.2.2 Liquid Bath Products
2.2.3 Bath Additives
2.2.4 Bar Soaps
2.3 Bath and Shower Products Sales by Type
2.3.1 Global Bath and Shower Products Sales Market Share by Type (2020-2025)
2.3.2 Global Bath and Shower Products Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bath and Shower Products Sale Price by Type (2020-2025)
2.4 Bath and Shower Products Segment by Application
2.4.1 Supermarkets and Hypermarkets
2.4.2 Specialist Stores
2.4.3 Drugstores
2.4.4 Others
2.5 Bath and Shower Products Sales by Application
2.5.1 Global Bath and Shower Products Sale Market Share by Application (2020-2025)
2.5.2 Global Bath and Shower Products Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bath and Shower Products Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Bath and Shower Products Breakdown Data by Company
3.1.1 Global Bath and Shower Products Annual Sales by Company (2020-2025)
3.1.2 Global Bath and Shower Products Sales Market Share by Company (2020-2025)
3.2 Global Bath and Shower Products Annual Revenue by Company (2020-2025)
3.2.1 Global Bath and Shower Products Revenue by Company (2020-2025)
3.2.2 Global Bath and Shower Products Revenue Market Share by Company (2020-2025)
3.3 Global Bath and Shower Products Sale Price by Company
3.4 Key Manufacturers Bath and Shower Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bath and Shower Products Product Location Distribution
3.4.2 Players Bath and Shower Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BATH AND SHOWER PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Bath and Shower Products Market Size by Geographic Region (2020-2025)
4.1.1 Global Bath and Shower Products Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bath and Shower Products Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bath and Shower Products Market Size by Country/Region (2020-2025)
4.2.1 Global Bath and Shower Products Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bath and Shower Products Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bath and Shower Products Sales Growth
4.4 APAC Bath and Shower Products Sales Growth
4.5 Europe Bath and Shower Products Sales Growth
4.6 Middle East & Africa Bath and Shower Products Sales Growth
5 AMERICAS
5.1 Americas Bath and Shower Products Sales by Country
5.1.1 Americas Bath and Shower Products Sales by Country (2020-2025)
5.1.2 Americas Bath and Shower Products Revenue by Country (2020-2025)
5.2 Americas Bath and Shower Products Sales by Type (2020-2025)
5.3 Americas Bath and Shower Products Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bath and Shower Products Sales by Region
6.1.1 APAC Bath and Shower Products Sales by Region (2020-2025)
6.1.2 APAC Bath and Shower Products Revenue by Region (2020-2025)
6.2 APAC Bath and Shower Products Sales by Type (2020-2025)
6.3 APAC Bath and Shower Products Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bath and Shower Products by Country
7.1.1 Europe Bath and Shower Products Sales by Country (2020-2025)
7.1.2 Europe Bath and Shower Products Revenue by Country (2020-2025)
7.2 Europe Bath and Shower Products Sales by Type (2020-2025)
7.3 Europe Bath and Shower Products Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bath and Shower Products by Country
8.1.1 Middle East & Africa Bath and Shower Products Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bath and Shower Products Revenue by Country (2020-2025)
8.2 Middle East & Africa Bath and Shower Products Sales by Type (2020-2025)
8.3 Middle East & Africa Bath and Shower Products Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bath and Shower Products
10.3 Manufacturing Process Analysis of Bath and Shower Products
10.4 Industry Chain Structure of Bath and Shower Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bath and Shower Products Distributors
11.3 Bath and Shower Products Customer
12 WORLD FORECAST REVIEW FOR BATH AND SHOWER PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Bath and Shower Products Market Size Forecast by Region
12.1.1 Global Bath and Shower Products Forecast by Region (2026-2031)
12.1.2 Global Bath and Shower Products Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bath and Shower Products Forecast by Type (2026-2031)
12.7 Global Bath and Shower Products Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Bath and Shower Products Product Portfolios and Specifications
13.1.3 Johnson & Johnson Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 L'Oreal
13.2.1 L'Oreal Company Information
13.2.2 L'Oreal Bath and Shower Products Product Portfolios and Specifications
13.2.3 L'Oreal Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 L'Oreal Main Business Overview
13.2.5 L'Oreal Latest Developments
13.3 P&G
13.3.1 P&G Company Information
13.3.2 P&G Bath and Shower Products Product Portfolios and Specifications
13.3.3 P&G Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 P&G Main Business Overview
13.3.5 P&G Latest Developments
13.4 Unilever
13.4.1 Unilever Company Information
13.4.2 Unilever Bath and Shower Products Product Portfolios and Specifications
13.4.3 Unilever Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Unilever Main Business Overview
13.4.5 Unilever Latest Developments
13.5 Colgate-Palmolive
13.5.1 Colgate-Palmolive Company Information
13.5.2 Colgate-Palmolive Bath and Shower Products Product Portfolios and Specifications
13.5.3 Colgate-Palmolive Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Colgate-Palmolive Main Business Overview
13.5.5 Colgate-Palmolive Latest Developments
13.6 Avon
13.6.1 Avon Company Information
13.6.2 Avon Bath and Shower Products Product Portfolios and Specifications
13.6.3 Avon Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Avon Main Business Overview
13.6.5 Avon Latest Developments
13.7 Bath and Body Works
13.7.1 Bath and Body Works Company Information
13.7.2 Bath and Body Works Bath and Shower Products Product Portfolios and Specifications
13.7.3 Bath and Body Works Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bath and Body Works Main Business Overview
13.7.5 Bath and Body Works Latest Developments
13.8 Coty
13.8.1 Coty Company Information
13.8.2 Coty Bath and Shower Products Product Portfolios and Specifications
13.8.3 Coty Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Coty Main Business Overview
13.8.5 Coty Latest Developments
13.9 Estee Lauder
13.9.1 Estee Lauder Company Information
13.9.2 Estee Lauder Bath and Shower Products Product Portfolios and Specifications
13.9.3 Estee Lauder Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Estee Lauder Main Business Overview
13.9.5 Estee Lauder Latest Developments
13.10 Kao
13.10.1 Kao Company Information
13.10.2 Kao Bath and Shower Products Product Portfolios and Specifications
13.10.3 Kao Bath and Shower Products Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kao Main Business Overview
13.10.5 Kao Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-opioid Pain Patches Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Pain Patches Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocaine Patch
Table 4. Major Players of Diclofenac Patch
Table 5. Major Players of Methyl Salicylate Patch
Table 6. Major Players of Capsaicin Patch
Table 7. Major Players of Ketoprofen Patch
Table 8. Major Players of Others
Table 9. Global Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Table 11. Global Non-opioid Pain Patches Revenue by Type (2020-2025) & ($ million)
Table 12. Global Non-opioid Pain Patches Revenue Market Share by Type (2020-2025)
Table 13. Global Non-opioid Pain Patches Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Non-opioid Pain Patches Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Non-opioid Pain Patches Sale Market Share by Application (2020-2025)
Table 16. Global Non-opioid Pain Patches Revenue by Application (2020-2025) & ($ million)
Table 17. Global Non-opioid Pain Patches Revenue Market Share by Application (2020-2025)
Table 18. Global Non-opioid Pain Patches Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Non-opioid Pain Patches Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Non-opioid Pain Patches Sales Market Share by Company (2020-2025)
Table 21. Global Non-opioid Pain Patches Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Non-opioid Pain Patches Revenue Market Share by Company (2020-2025)
Table 23. Global Non-opioid Pain Patches Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Non-opioid Pain Patches Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Pain Patches Products Offered
Table 26. Non-opioid Pain Patches Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Non-opioid Pain Patches Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Non-opioid Pain Patches Sales Market Share Geographic Region (2020-2025)
Table 31. Global Non-opioid Pain Patches Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Non-opioid Pain Patches Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Non-opioid Pain Patches Sales Market Share by Country/Region (2020-2025)
Table 35. Global Non-opioid Pain Patches Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Non-opioid Pain Patches Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Non-opioid Pain Patches Sales Market Share by Country (2020-2025)
Table 39. Americas Non-opioid Pain Patches Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Non-opioid Pain Patches Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Non-opioid Pain Patches Sales Market Share by Region (2020-2025)
Table 44. APAC Non-opioid Pain Patches Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Non-opioid Pain Patches Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patches
Table 56. Key Market Challenges & Risks of Non-opioid Pain Patches
Table 57. Key Industry Trends of Non-opioid Pain Patches
Table 58. Non-opioid Pain Patches Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Non-opioid Pain Patches Distributors List
Table 61. Non-opioid Pain Patches Customer List
Table 62. Global Non-opioid Pain Patches Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Non-opioid Pain Patches Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Non-opioid Pain Patches Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Non-opioid Pain Patches Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Non-opioid Pain Patches Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Non-opioid Pain Patches Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Non-opioid Pain Patches Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Non-opioid Pain Patches Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Non-opioid Pain Patches Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Non-opioid Pain Patches Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Non-opioid Pain Patches Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Non-opioid Pain Patches Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Non-opioid Pain Patches Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Non-opioid Pain Patches Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Pfizer Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 77. Pfizer Non-opioid Pain Patches Product Portfolios and Specifications
Table 78. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. GlaxoSmithKline Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 82. GlaxoSmithKline Non-opioid Pain Patches Product Portfolios and Specifications
Table 83. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline Latest Developments
Table 86. Johnson & Johnson Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson Non-opioid Pain Patches Product Portfolios and Specifications
Table 88. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. Novartis AG Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis AG Non-opioid Pain Patches Product Portfolios and Specifications
Table 93. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Novartis AG Main Business
Table 95. Novartis AG Latest Developments
Table 96. Mylan N.V. Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 97. Mylan N.V. Non-opioid Pain Patches Product Portfolios and Specifications
Table 98. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Mylan N.V. Main Business
Table 100. Mylan N.V. Latest Developments
Table 101. Teva Pharmaceutical Industries Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 102. Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolios and Specifications
Table 103. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Teva Pharmaceutical Industries Main Business
Table 105. Teva Pharmaceutical Industries Latest Developments
Table 106. Hisamitsu Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 107. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolios and Specifications
Table 108. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. Hisamitsu Pharmaceutical Main Business
Table 110. Hisamitsu Pharmaceutical Latest Developments
Table 111. TEH SENG Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 112. TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolios and Specifications
Table 113. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. TEH SENG Pharmaceutical Main Business
Table 115. TEH SENG Pharmaceutical Latest Developments
Table 116. Teikoku Seiyaku Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 117. Teikoku Seiyaku Non-opioid Pain Patches Product Portfolios and Specifications
Table 118. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. Teikoku Seiyaku Main Business
Table 120. Teikoku Seiyaku Latest Developments
Table 121. IBSA Institut Biochimque SA Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 122. IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolios and Specifications
Table 123. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. IBSA Institut Biochimque SA Main Business
Table 125. IBSA Institut Biochimque SA Latest Developments
Table 126. Acorda Therapeutics Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 127. Acorda Therapeutics Non-opioid Pain Patches Product Portfolios and Specifications
Table 128. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 129. Acorda Therapeutics Main Business
Table 130. Acorda Therapeutics Latest Developments
Table 131. Allergan PLC Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 132. Allergan PLC Non-opioid Pain Patches Product Portfolios and Specifications
Table 133. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 134. Allergan PLC Main Business
Table 135. Allergan PLC Latest Developments
Table 136. Endo International Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 137. Endo International Non-opioid Pain Patches Product Portfolios and Specifications
Table 138. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 139. Endo International Main Business
Table 140. Endo International Latest Developments
Table 1. Non-opioid Pain Patches Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Pain Patches Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocaine Patch
Table 4. Major Players of Diclofenac Patch
Table 5. Major Players of Methyl Salicylate Patch
Table 6. Major Players of Capsaicin Patch
Table 7. Major Players of Ketoprofen Patch
Table 8. Major Players of Others
Table 9. Global Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 10. Global Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Table 11. Global Non-opioid Pain Patches Revenue by Type (2020-2025) & ($ million)
Table 12. Global Non-opioid Pain Patches Revenue Market Share by Type (2020-2025)
Table 13. Global Non-opioid Pain Patches Sale Price by Type (2020-2025) & (USD/Pcs)
Table 14. Global Non-opioid Pain Patches Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Non-opioid Pain Patches Sale Market Share by Application (2020-2025)
Table 16. Global Non-opioid Pain Patches Revenue by Application (2020-2025) & ($ million)
Table 17. Global Non-opioid Pain Patches Revenue Market Share by Application (2020-2025)
Table 18. Global Non-opioid Pain Patches Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Non-opioid Pain Patches Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Non-opioid Pain Patches Sales Market Share by Company (2020-2025)
Table 21. Global Non-opioid Pain Patches Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Non-opioid Pain Patches Revenue Market Share by Company (2020-2025)
Table 23. Global Non-opioid Pain Patches Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Non-opioid Pain Patches Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Pain Patches Products Offered
Table 26. Non-opioid Pain Patches Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Non-opioid Pain Patches Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Non-opioid Pain Patches Sales Market Share Geographic Region (2020-2025)
Table 31. Global Non-opioid Pain Patches Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Non-opioid Pain Patches Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Non-opioid Pain Patches Sales Market Share by Country/Region (2020-2025)
Table 35. Global Non-opioid Pain Patches Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Non-opioid Pain Patches Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Non-opioid Pain Patches Sales Market Share by Country (2020-2025)
Table 39. Americas Non-opioid Pain Patches Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 41. Americas Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Non-opioid Pain Patches Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Non-opioid Pain Patches Sales Market Share by Region (2020-2025)
Table 44. APAC Non-opioid Pain Patches Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 46. APAC Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Non-opioid Pain Patches Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 50. Europe Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Non-opioid Pain Patches Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Non-opioid Pain Patches Sales by Type (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Non-opioid Pain Patches Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patches
Table 56. Key Market Challenges & Risks of Non-opioid Pain Patches
Table 57. Key Industry Trends of Non-opioid Pain Patches
Table 58. Non-opioid Pain Patches Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Non-opioid Pain Patches Distributors List
Table 61. Non-opioid Pain Patches Customer List
Table 62. Global Non-opioid Pain Patches Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. Global Non-opioid Pain Patches Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Non-opioid Pain Patches Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Non-opioid Pain Patches Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Non-opioid Pain Patches Sales Forecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Non-opioid Pain Patches Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Non-opioid Pain Patches Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Non-opioid Pain Patches Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Non-opioid Pain Patches Sales Forecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Non-opioid Pain Patches Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Non-opioid Pain Patches Sales Forecast by Type (2026-2031) & (K Pcs)
Table 73. Global Non-opioid Pain Patches Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Non-opioid Pain Patches Sales Forecast by Application (2026-2031) & (K Pcs)
Table 75. Global Non-opioid Pain Patches Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Pfizer Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 77. Pfizer Non-opioid Pain Patches Product Portfolios and Specifications
Table 78. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Pfizer Main Business
Table 80. Pfizer Latest Developments
Table 81. GlaxoSmithKline Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 82. GlaxoSmithKline Non-opioid Pain Patches Product Portfolios and Specifications
Table 83. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline Latest Developments
Table 86. Johnson & Johnson Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson Non-opioid Pain Patches Product Portfolios and Specifications
Table 88. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. Novartis AG Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis AG Non-opioid Pain Patches Product Portfolios and Specifications
Table 93. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. Novartis AG Main Business
Table 95. Novartis AG Latest Developments
Table 96. Mylan N.V. Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 97. Mylan N.V. Non-opioid Pain Patches Product Portfolios and Specifications
Table 98. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Mylan N.V. Main Business
Table 100. Mylan N.V. Latest Developments
Table 101. Teva Pharmaceutical Industries Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 102. Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolios and Specifications
Table 103. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Teva Pharmaceutical Industries Main Business
Table 105. Teva Pharmaceutical Industries Latest Developments
Table 106. Hisamitsu Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 107. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolios and Specifications
Table 108. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. Hisamitsu Pharmaceutical Main Business
Table 110. Hisamitsu Pharmaceutical Latest Developments
Table 111. TEH SENG Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 112. TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolios and Specifications
Table 113. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. TEH SENG Pharmaceutical Main Business
Table 115. TEH SENG Pharmaceutical Latest Developments
Table 116. Teikoku Seiyaku Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 117. Teikoku Seiyaku Non-opioid Pain Patches Product Portfolios and Specifications
Table 118. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. Teikoku Seiyaku Main Business
Table 120. Teikoku Seiyaku Latest Developments
Table 121. IBSA Institut Biochimque SA Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 122. IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolios and Specifications
Table 123. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. IBSA Institut Biochimque SA Main Business
Table 125. IBSA Institut Biochimque SA Latest Developments
Table 126. Acorda Therapeutics Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 127. Acorda Therapeutics Non-opioid Pain Patches Product Portfolios and Specifications
Table 128. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 129. Acorda Therapeutics Main Business
Table 130. Acorda Therapeutics Latest Developments
Table 131. Allergan PLC Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 132. Allergan PLC Non-opioid Pain Patches Product Portfolios and Specifications
Table 133. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 134. Allergan PLC Main Business
Table 135. Allergan PLC Latest Developments
Table 136. Endo International Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 137. Endo International Non-opioid Pain Patches Product Portfolios and Specifications
Table 138. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 139. Endo International Main Business
Table 140. Endo International Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-opioid Pain Patches
Figure 2. Non-opioid Pain Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Pain Patches Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Non-opioid Pain Patches Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Pain Patches Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Pain Patches Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Pain Patches Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocaine Patch
Figure 12. Product Picture of Diclofenac Patch
Figure 13. Product Picture of Methyl Salicylate Patch
Figure 14. Product Picture of Capsaicin Patch
Figure 15. Product Picture of Ketoprofen Patch
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Pain Patches Sales Market Share by Type in 2025
Figure 18. Global Non-opioid Pain Patches Revenue Market Share by Type (2020-2025)
Figure 19. Non-opioid Pain Patches Consumed in Hospital Pharmacies
Figure 20. Global Non-opioid Pain Patches Market: Hospital Pharmacies (2020-2025) & (K Pcs)
Figure 21. Non-opioid Pain Patches Consumed in Independent Pharmacies & Drug Stores
Figure 22. Global Non-opioid Pain Patches Market: Independent Pharmacies & Drug Stores (2020-2025) & (K Pcs)
Figure 23. Non-opioid Pain Patches Consumed in Online Pharmacies
Figure 24. Global Non-opioid Pain Patches Market: Online Pharmacies (2020-2025) & (K Pcs)
Figure 25. Global Non-opioid Pain Patches Sale Market Share by Application (2024)
Figure 26. Global Non-opioid Pain Patches Revenue Market Share by Application in 2025
Figure 27. Non-opioid Pain Patches Sales by Company in 2025 (K Pcs)
Figure 28. Global Non-opioid Pain Patches Sales Market Share by Company in 2025
Figure 29. Non-opioid Pain Patches Revenue by Company in 2025 ($ millions)
Figure 30. Global Non-opioid Pain Patches Revenue Market Share by Company in 2025
Figure 31. Global Non-opioid Pain Patches Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 34. Americas Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 35. APAC Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 36. APAC Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 37. Europe Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 38. Europe Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 41. Americas Non-opioid Pain Patches Sales Market Share by Country in 2025
Figure 42. Americas Non-opioid Pain Patches Revenue Market Share by Country (2020-2025)
Figure 43. Americas Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 44. Americas Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 45. United States Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Non-opioid Pain Patches Sales Market Share by Region in 2025
Figure 50. APAC Non-opioid Pain Patches Revenue Market Share by Region (2020-2025)
Figure 51. APAC Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 52. APAC Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 53. China Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 57. India Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Non-opioid Pain Patches Sales Market Share by Country in 2025
Figure 61. Europe Non-opioid Pain Patches Revenue Market Share by Country (2020-2025)
Figure 62. Europe Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 63. Europe Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 64. Germany Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 65. France Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 72. Egypt Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Non-opioid Pain Patches in 2025
Figure 78. Manufacturing Process Analysis of Non-opioid Pain Patches
Figure 79. Industry Chain Structure of Non-opioid Pain Patches
Figure 80. Channels of Distribution
Figure 81. Global Non-opioid Pain Patches Sales Market Forecast by Region (2026-2031)
Figure 82. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Non-opioid Pain Patches Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Non-opioid Pain Patches
Figure 2. Non-opioid Pain Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Pain Patches Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Non-opioid Pain Patches Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Pain Patches Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Pain Patches Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Pain Patches Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocaine Patch
Figure 12. Product Picture of Diclofenac Patch
Figure 13. Product Picture of Methyl Salicylate Patch
Figure 14. Product Picture of Capsaicin Patch
Figure 15. Product Picture of Ketoprofen Patch
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Pain Patches Sales Market Share by Type in 2025
Figure 18. Global Non-opioid Pain Patches Revenue Market Share by Type (2020-2025)
Figure 19. Non-opioid Pain Patches Consumed in Hospital Pharmacies
Figure 20. Global Non-opioid Pain Patches Market: Hospital Pharmacies (2020-2025) & (K Pcs)
Figure 21. Non-opioid Pain Patches Consumed in Independent Pharmacies & Drug Stores
Figure 22. Global Non-opioid Pain Patches Market: Independent Pharmacies & Drug Stores (2020-2025) & (K Pcs)
Figure 23. Non-opioid Pain Patches Consumed in Online Pharmacies
Figure 24. Global Non-opioid Pain Patches Market: Online Pharmacies (2020-2025) & (K Pcs)
Figure 25. Global Non-opioid Pain Patches Sale Market Share by Application (2024)
Figure 26. Global Non-opioid Pain Patches Revenue Market Share by Application in 2025
Figure 27. Non-opioid Pain Patches Sales by Company in 2025 (K Pcs)
Figure 28. Global Non-opioid Pain Patches Sales Market Share by Company in 2025
Figure 29. Non-opioid Pain Patches Revenue by Company in 2025 ($ millions)
Figure 30. Global Non-opioid Pain Patches Revenue Market Share by Company in 2025
Figure 31. Global Non-opioid Pain Patches Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 34. Americas Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 35. APAC Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 36. APAC Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 37. Europe Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 38. Europe Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Non-opioid Pain Patches Sales 2020-2025 (K Pcs)
Figure 40. Middle East & Africa Non-opioid Pain Patches Revenue 2020-2025 ($ millions)
Figure 41. Americas Non-opioid Pain Patches Sales Market Share by Country in 2025
Figure 42. Americas Non-opioid Pain Patches Revenue Market Share by Country (2020-2025)
Figure 43. Americas Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 44. Americas Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 45. United States Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Non-opioid Pain Patches Sales Market Share by Region in 2025
Figure 50. APAC Non-opioid Pain Patches Revenue Market Share by Region (2020-2025)
Figure 51. APAC Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 52. APAC Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 53. China Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 57. India Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Non-opioid Pain Patches Sales Market Share by Country in 2025
Figure 61. Europe Non-opioid Pain Patches Revenue Market Share by Country (2020-2025)
Figure 62. Europe Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 63. Europe Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 64. Germany Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 65. France Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Application (2020-2025)
Figure 72. Egypt Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Non-opioid Pain Patches Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Non-opioid Pain Patches in 2025
Figure 78. Manufacturing Process Analysis of Non-opioid Pain Patches
Figure 79. Industry Chain Structure of Non-opioid Pain Patches
Figure 80. Channels of Distribution
Figure 81. Global Non-opioid Pain Patches Sales Market Forecast by Region (2026-2031)
Figure 82. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Non-opioid Pain Patches Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2026-2031)
